Corrigendum to “Triazolo[4,5-d]pyrimidines as validated general control nonderepressible 2 (GCN2) protein kinase inhibitors reduce growth of leukemia cells” [Comput. Struct. Biotechnol. J. 16 (2018) 350–360]
Titel:
Corrigendum to “Triazolo[4,5-d]pyrimidines as validated general control nonderepressible 2 (GCN2) protein kinase inhibitors reduce growth of leukemia cells” [Comput. Struct. Biotechnol. J. 16 (2018) 350–360]
Auteur:
Lough, Lea Sherman, Dan Becerra-Flores, Manuel Vasudevan, Deepika Lavinda, Olga Ni, Eric Wang, Hong Ryoo, Hyung Don Tibes, Raoul Cardozo, Timothy
Verschenen in:
Computational and structural biotechnology journal